Northwestern Mutual Wealth Management
LRMR icon

Northwestern Mutual Wealth Management’s Larimar Therapeutics LRMR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-19
Closed -$2K – 2170
2016
Q1 		$2K Buy
+19
New +$1.5K ﹤0.01% 1897

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Northwestern Mutual Wealth Management's LRMR Position: Q2 2016 in Review

Northwestern Mutual Wealth Management sold out of Larimar Therapeutics (LRMR) in Q2 2016, closing a stake of 19 shares — an estimated $2K sold.

Northwestern Mutual Wealth Management first reported a position in LRMR in Q1 2016 and held it in 1 quarter. The position peaked at $2K in Q1 2016. 73 funds tracked by Wall St. Rank hold LRMR as of Q2 2016.

  • Northwestern Mutual Wealth Management reported no remaining Larimar Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 19 Larimar Therapeutics shares in Q2 2016, an estimated $2K.
  • Northwestern Mutual Wealth Management first reported a position in Larimar Therapeutics in Q1 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Larimar Therapeutics position peaked at $2K in Q1 2016.
  • 73 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2016.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2016, filed 29 Aug 2016.